June 24, 2025

ACHP calls on policymakers to restore accountability to the FDA’s Accelerated Approval Pathway so effective therapies can reach patients facing serious, life-threatening diseases.

Loading...

Taking too long?

Reload document

|

Open in new tab

Download the Infographic

When Speed Undermines Evidence: The FDA’s Flawed Accelerated Approval Pathway

New from ACHP